Keros Therapeutics (KROS) Stock Chart & Stock Price History $15.76 +0.01 (+0.03%) As of 01:52 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Keros Therapeutics Stock Price Performance The Keros Therapeutics (KROS) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 72.05%, with a year-to-date return of -0.41%. In the past month, the stock has increased 14.99%, reflecting recent market activity. As of the latest close, Keros Therapeutics traded at $15.76 with a market cap of $640.17 million and volume of 235,090 shares. Five years ago, the stock traded at $44.51, representing a 64.58% decrease over that period. At the time, it had a market cap of $998.74 million and a volume of 42,488 shares. Receive KROS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Keros Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+1.12%1 Month Performance+14.99%3 Month Performance+15.58%Year-To-Date Performance-0.41%1 Year Performance-72.05%5 Year Performance-64.58% KROS Stock Chart for Friday, September, 12, 2025 KROS Chart by TradingView Keros Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/11/2025$15.65$15.76+0.70%$15.85$15.62235,090 shs$640.17 million09/10/2025$15.71$15.65-0.38%$15.75$15.23287,751 shs$635.63 million09/09/2025$15.47$15.71+1.55%$15.73$15.32199,631 shs$638.14 million09/08/2025$15.59$15.47-0.77%$15.65$15.25286,761 shs$628.39 million09/05/2025$15.55$15.59+0.26%$16.00$15.48537,578 shs$633.27 million09/04/2025$15.76$15.55-1.33%$15.73$15.38201,843 shs$631.56 million09/03/2025$15.72$15.76+0.25%$16.04$15.60271,848 shs$640.17 million09/02/2025$15.21$15.72+3.35%$16.07$15.22475,978 shs$638.55 million09/01/2025$15.21$15.21$15.38$14.98586,020 shs$617.75 million08/29/2025$15.25$15.21-0.26%$15.38$14.98586,020 shs$617.75 million Get the Latest News and Ratings for KROS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Keros Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 08/28/2025$15.52$15.25-1.74%$15.56$15.22242,817 shs$619.46 million08/27/2025$14.91$15.52+4.09%$15.83$14.82476,664 shs$630.42 million08/26/2025$14.76$14.91+1.02%$15.08$14.57577,653 shs$605.57 million08/25/2025$15.56$14.76-5.14%$15.69$14.72293,764 shs$599.55 million08/22/2025$15.17$15.56+2.57%$15.81$15.15675,014 shs$632.05 million08/21/2025$14.23$15.17+6.61%$15.23$14.111.04 million shs$616.21 million08/20/2025$14.49$14.23-1.79%$15.39$14.04800,164 shs$577.95 million08/19/2025$14.52$14.49-0.21%$14.66$14.26523,075 shs$588.58 million08/18/2025$14.48$14.52+0.28%$14.66$14.38272,065 shs$589.80 million08/15/2025$14.42$14.48+0.42%$14.53$14.13383,521 shs$588.18 million08/14/2025$13.96$14.42+3.30%$14.67$13.78460,243 shs$585.74 million08/13/2025$13.71$13.96+1.82%$13.98$13.80431,825 shs$566.99 million08/12/2025$13.35$13.71+2.70%$13.76$13.44305,989 shs$556.90 million08/11/2025$13.73$13.35-2.77%$13.75$13.28467,747 shs$542.28 million Related Companies Alvotech Stock Price Chart Tarsus Pharmaceuticals Stock Price Chart Catalyst Pharmaceuticals Stock Price Chart CG Oncology Stock Price Chart ImmunityBio Stock Price Chart IDEAYA Biosciences Stock Price Chart Ocular Therapeutix Stock Price Chart Denali Therapeutics Stock Price Chart Centessa Pharmaceuticals Stock Price Chart Mineralys Therapeutics Stock Price Chart Receive KROS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Keros Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:KROS) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Keros Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Keros Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KROS Stock Alerts